What Will Happen To Coverage Of Covid-19 Tests, Vaccines, And Treatments Once The Government Is No Longer The Predominant Purchaser?

Posted on AllSides September 6th, 2022
From The Center
AFP VIA GETTY IMAGES
OPINION

In August, the Biden Administration announced it will stop being the predominant purchaser of Covid-19 vaccines, treatments, and tests at some point this autumn, as it moves “beyond the crisis phase of the pandemic.” White House Covid-19 Response Team coordinator Dr. Ashish Jha said his “hope is that in 2023, you're going to see the commercialization of almost all of these products.”

One product that will not be impacted by this change in procurement policy is the updated Omicron BA.5-specific vaccine. The Biden Administration has signed purchase agreements for these vaccine doses....

Read full story
Some content from this outlet may be limited or behind a paywall.

Forbes

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
110252/85865
See full bias rating for Forbes
Learn about media bias
https://www.forbes.com/sites/joshuacohen/2022/09/05/what-will-happen-to-coverage-of-covid-19-tests-vaccines-and-treatments-once-the-government-is-no-longer-the-predominant-purchaser/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right